Norman D. Schwartz - 03 Sep 2021 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
Chairman, President, and CEO, Director, 10%+ Owner
Signature
/s/ Norman D. Schwartz
Issuer symbol
BIO
Transactions as of
03 Sep 2021
Net transactions value
-$3,057,481
Form type
4
Filing time
08 Sep 2021, 12:09:26 UTC
Previous filing
03 Sep 2021
Next filing
09 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +2,319 +0.55% $0.000000 422,200 03 Sep 2021 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability $942,655 -1,150 -0.27% $819.70 421,050 03 Sep 2021 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +2,600 +0.62% $0.000000 423,650 04 Sep 2021 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability $1,057,413 -1,290 -0.3% $819.70 422,360 04 Sep 2021 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +2,600 +0.62% $0.000000 424,960 05 Sep 2021 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability $1,057,413 -1,290 -0.3% $819.70 423,670 05 Sep 2021 Direct
holding BIO Bio-Rad B Common Stock 12,838 03 Sep 2021 By Spouse F2
holding BIO Bio-Rad B Common Stock 4,060,054 03 Sep 2021 By Blue Raven Partners, L.P. F3
holding BIO Bio-Rad B Common Stock 298,274 03 Sep 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO Restricted Stock Units Options Exercise $0 -2,319 -25% $0.000000 6,959 03 Sep 2021 Bio-Rad A Common Stock 2,319 $0.000000 Direct F4, F5
transaction BIO Restricted Stock Units Options Exercise $0 -2,600 -33% $0.000000 5,200 04 Sep 2021 Bio-Rad A Common Stock 2,600 $0.000000 Direct F4, F6
transaction BIO Restricted Stock Units Options Exercise $0 -2,600 -50% $0.000000 2,600 05 Sep 2021 Bio-Rad A Common Stock 2,600 $0.000000 Direct F4, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 The reporting person disclaims beneficial ownership of these shares.
F3 The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F4 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F5 On September 3, 2019, the reporting person was granted 11,597 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.
F6 On September 4, 2018, the reporting person was granted 13,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.
F7 On September 5, 2017, the reporting person was granted 13,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.